Semapimod

( DrugBank: Semapimod / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
96	クローン病	5

96. クローン病

臨床試験数 : 2,442 / 薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209

trials per page:

Showing 1 to 5 of 5 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00950105 (ClinicalTrials.gov)	July 2009	29/7/2009	Single Ascending Dose Study of Oral CPSI-2364 (Semapimod)	A Phase 1, Single Center, Randomized, Double-Blind, Placebo-Controlled Single Ascending Dose Study t ...	Crohn's Disease	Drug: CPSI-2364 or placebo	Ferring Pharmaceuticals	NULL	Completed	18 Years	55 Years	Both	30	Phase 1	United States
2	NCT00741910 (ClinicalTrials.gov)	July 2003	22/8/2008	Extension Study of Semapimod 60 mg IV x 3 Days	Extension Study of CNI-1493 for Treatment of Moderate to Severe Crohn's Disease	Crohn's Disease	Drug: Semapimod	Ferring Pharmaceuticals	NULL	Completed	18 Years	N/A	Both	15	Phase 2	United States;Germany;Israel;Netherlands
3	NCT00740103 (ClinicalTrials.gov)	December 2002	21/8/2008	Long-term Study of Semapimod (CNI-1493) for Treatment of Crohn's Disease	Long-term Study of Semapimod(CNI-1493) for Treatment of Moderate to Severe Crohn's Disease With Refe ...	Crohn's Disease	Drug: Semapimod	Ferring Pharmaceuticals	NULL	Completed	18 Years	N/A	Both	119	Phase 2	United States;Belgium;Germany;Israel;Netherlands
4	NCT00739986 (ClinicalTrials.gov)	October 2002	20/8/2008	Semapimod for Treatment of Moderate to Severe Crohn's Disease 1 or 3 Days' Treatment Versus Placebo	A Randomized, Double-Blind, Placebo-controlled Study of CNI-1493 for Treatment of Moderate to Severe ...	Crohn's Disease	Drug: Semapimod;Drug: Placebo	Ferring Pharmaceuticals	NULL	Completed	18 Years	N/A	Both	152	Phase 2	United States;Belgium;Germany;Israel;Netherlands
5	NCT00038766 (ClinicalTrials.gov)	June 2002	5/6/2002	CNI-1493 for Treatment of Moderate to Severe Crohn's Disease	A Randomized, Double-Blind, Placebo-controlled Study of CNI-1493 for Treatment of Moderate to Severe ...	Crohn Disease	Drug: semapimod;Drug: placebo	Ferring Pharmaceuticals	NULL	Terminated	18 Years	N/A	Both	33	Phase 2	United States

First Previous1Next Last